Washington Examiner

Amazon Pharmacy slashes insulin prices to increase affordability.

Amazon Pharmacy Expands Access to Critical Care with Automatic Coupons

Amazon Pharmacy announced on Tuesday that it is taking steps to make critical care more accessible by automatically applying manufacturer coupons and savings discounts to ⁤over 15 insulin and diabetes management brands.

“The reason why Amazon Pharmacy is doing something different is because many ⁤patients don’t know that coupons readily‍ exist,” Chief Medical Officer of Amazon Pharmacy⁣ Vin Gupta told Forbes. “In fact, 85% of the time that a medication‍ with ⁤an available coupon is prescribed, the coupon is never used. We are trying to close that gap for both insulin and a broader set⁤ of medications, and really unlock the value behind those ⁣savings for patients automatically.”

Efforts to Lower Insulin Prices

Eli Lilly, Novo Nordisk, and​ Sanofi, the three major players ‌controlling 90% of the insulin market ⁣in the United States, have announced plans ‍to ⁣cut insulin prices by‌ at least 70% by 2024. In ‍the meantime, they​ have issued more manufacturer coupons to help lower prices.

However, a report released​ by Sen. Elizabeth Warren (D-MA) found that people without health insurance still ⁤pay an average of $98 per vial for Eli Lilly’s generic insulin ‌product. Additionally, one-third of pharmacies charge more than $164 per vial, despite the company’s pledge‌ to ⁣reduce the​ price to $25 per vial.

Government Initiatives and ‌Diabetes Statistics

The Centers for Medicare ⁢and Medicaid Services have implemented the Inflation Reduction Act, which includes a⁢ $35 cap on insulin monthly co-pays for⁤ Medicare Part D patients ⁣and the elimination ‍of deductibles for insulin.

According to the Centers for​ Disease Control ⁣and Prevention, there⁣ are approximately 37.3 million Americans with diabetes⁤ and 96 ‍million with pre-diabetes.‍ The American Diabetes Association estimates that there are 8.4 million insulin-dependent diabetics in the ‍U.S.

Positive⁢ Response from the American Diabetes Association

“Access to affordable ‍diabetes medications and technology can help people⁢ living with diabetes stay healthy and avoid complications,” said Charles Henderson, CEO of the ADA. “We applaud Amazon Pharmacy for innovating on behalf of people with diabetes and taking important action to help ensure they easily access the treatments they‍ need through a transparent purchase process that​ automatically applies ​any eligible discounts.”

Amazon Pharmacy’s Competitive Moves

Amazon has been making strategic‍ moves to compete with ⁢major players in the pharmaceutical industry, such as CVS and Walgreens. In January, they launched a $5-a-month program for 50 generic‌ medications used to treat over 80 chronic medical conditions.

“What [is Amazon] really good at? We are good at acting based off of our core ‌retail roots — driving convenience, value, and ‍affordability through upfront pricing and direct delivery,” Gupta said. “This is how we are trying to get closer to our customers — by really keeping ⁢their priorities first.”

Click here to read more from The ⁣Washington Examiner.



" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases

Related Articles

Sponsored Content
Back to top button
Available for Amazon Prime
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker